The Future of Prosthetic Control.

Introducing a revolutionary implantable device that allows for intuitive motor control of a prosthetic device with multiple degrees of freedom.

DB+

THE PRODUCT

An Unparalelled Prosthetic Interface

Our innovative neuroprosthetic interface detects voluntary nerve and muscle control signals to facilitate naturalistic function of prosthetics.

OUR RESEARCH

Extraordinary Science to Breakthrough Prosthetic Technology

Our products are the result of over 20 years of basic science and clinical research and over $35 million in research funding.

DB+

Image Gallery

Video Gallery

WHO WE ARE

An Exceptional Leadership Team

DB+
Paul Cederna, MD
PRESIDENT
Tod Borton, CEO
CHIEF EXECUTIVE OFFICER
Alex Vaskov, PhD
CHIEF TECHNOLOGY OFFICER
Theodore Kung, MD
CHIEF MEDICAL OFFICER

QUESTIONS?

Contact Us

We are happy to answer any questions about our technology, our products, and our mission. Please allow 24-48 hours for our team to respond to your inquiry.

13 + 3 =